NURS6305 moves from managing individual disease states (NURS6303) to managing the complex, multi-morbid patients who define real-world adult and geriatric primary care. Most older adults have three or more chronic conditions simultaneously — and the clinical challenge is not managing any single condition but managing the interactions, contradictions, and competing priorities that arise when guideline-concordant care for one condition conflicts with optimal management of another.
Multi-morbidity complexity scenarios
| Clinical Scenario | Competing Guidelines | AGPCNP Decision-Making |
|---|---|---|
| Heart failure + CKD + diabetes | Metformin (diabetes first-line) contraindicated in severe CKD; SGLT2 inhibitors beneficial for HF and CKD but require eGFR monitoring; diuretics worsen renal function | Prioritize cardio-renal protection, use SGLT2 inhibitors (proven benefit in HFrEF + CKD), adjust diabetes targets, coordinate with nephrology and cardiology |
| Atrial fibrillation + fall risk + CKD | Anticoagulation reduces stroke risk but increases bleeding; CKD alters DOAC dosing; falls increase intracranial hemorrhage risk | CHA2DS2-VASc vs. HAS-BLED scoring, renal-adjusted DOAC dosing, falls prevention program, shared decision-making about anticoagulation benefit vs. risk |
| COPD + anxiety + insomnia | Benzodiazepines treat anxiety/insomnia but suppress respiratory drive in COPD; beta-blockers for anxiety may worsen bronchospasm | SSRIs for anxiety, CBT-I for insomnia, avoid benzodiazepines, consider cardioselective beta-blocker if needed (evidence supports safety in COPD) |
| Osteoporosis + GERD + CKD | Oral bisphosphonates (osteoporosis) worsen esophagitis; PPIs (GERD) increase fracture risk; IV bisphosphonates require adequate renal function | Denosumab (not renally cleared) for osteoporosis, step-down PPI to H2 blocker if possible, calcium and vitamin D with renal monitoring |
What NURS6305 covers
Polypharmacy management is a central theme. The average older adult with multiple chronic conditions takes 5–10 medications — each prescribed appropriately for its indication but collectively creating a drug-interaction network that no single prescriber may fully appreciate. NURS6305 teaches systematic medication reconciliation, deprescribing methodology (the evidence-based process of tapering or discontinuing medications whose harms outweigh benefits in the current clinical context), and the use of tools like the Beers Criteria, STOPP/START criteria, and Medication Appropriateness Index to evaluate appropriateness.
Care coordination for complex patients requires the AGPCNP to function as the primary care "quarterback" — managing referrals to specialists, ensuring specialist recommendations are integrated into the overall plan without conflicting with existing medications, tracking pending studies and follow-ups, coordinating transitions of care between hospital and home, and facilitating advance care planning conversations for patients with progressive chronic illness. NURS6305 builds these coordination competencies through complex case simulations that mirror real primary care panel management.
Working on a multi-morbidity case study, polypharmacy analysis, or complex care coordination paper?
Our AGPCNP writers develop complex patient analyses with the multi-system depth Capella's NURS6305 rubric requires.
Key topics in NURS6305
- Multi-morbidity management: competing guideline priorities, treatment hierarchy, goal-concordant care
- Polypharmacy and deprescribing: systematic medication review, Beers/STOPP-START, tapering protocols
- Complex pharmacotherapy: drug-drug and drug-disease interactions, renal/hepatic dose adjustments
- Care coordination: specialist referral management, transitions of care, chronic care model
- Advance care planning: goals of care conversations, advance directives, POLST, palliative care integration
- Cognitive impairment in primary care: dementia staging, caregiver support, driving assessment, safety planning
- Frailty assessment: Fried criteria, clinical frailty scale, treatment modification based on frailty status
- Pain management in elderly: multimodal approach, opioid risk assessment, non-pharmacological alternatives
Deprescribing: evidence-based medication discontinuation
- Identify medications with no current indication or where indication has changed
- Assess risk-benefit ratio for each medication in the current clinical context (not when originally prescribed)
- Prioritize stopping medications with highest harm potential (anticholinergics, sedative-hypnotics, long-acting sulfonylureas)
- Taper gradually — many medications cannot be stopped abruptly (PPIs, benzodiazepines, beta-blockers, SSRIs)
- Monitor for return of symptoms or withdrawal effects after discontinuation
- Involve the patient in deprescribing decisions — patient resistance is the most common barrier
Get Help With NURS6305
Complex case analyses, polypharmacy reviews, multi-morbidity management papers. Advanced AGPCNP coursework done right.
Place Your OrderView All ServicesRelated courses
Frequently asked questions
Goal-concordant care aligns treatment with the patient's values, preferences, and personally meaningful health goals rather than optimizing every biomarker to guideline targets. For an 85-year-old with heart failure, COPD, diabetes, and moderate dementia, achieving an A1C of 7.0% is less meaningful than maintaining comfort, staying at home, and avoiding hospitalizations. The AGPCNP's role is to elicit what matters most to the patient and family, then design a treatment plan that serves those goals — which may mean intentionally under-treating some conditions to prioritize quality of life over disease-specific metrics.
The Fried phenotype model defines frailty using five criteria: unintentional weight loss (>10 lbs or >5% body weight in past year), self-reported exhaustion, low physical activity, slow walking speed, and weak grip strength. Meeting 3+ criteria = frail; 1–2 = pre-frail; 0 = robust. Frailty status modifies treatment intensity: frail patients benefit less from aggressive chronic disease management (the intervention itself — complex medication regimens, procedure risks, dietary restrictions — may cause more harm than the disease being treated) and benefit more from interventions targeting function, nutrition, exercise, and falls prevention.
POLST (Physician/Provider Orders for Life-Sustaining Treatment) is an actionable medical order signed by a healthcare provider — it tells EMS and hospital staff exactly what to do: full treatment, limited interventions, or comfort measures only. An advance directive is a legal document expressing the patient's wishes, but it requires interpretation in the moment and may not be accessible in an emergency. POLST is designed for patients with serious illness or advanced frailty whose current health status makes specific treatment decisions clinically relevant now. The AGPCNP initiates POLST conversations based on clinical trajectory assessment — it should reflect a goals-of-care conversation, not just a form to sign.
Referral triggers include: conditions outside AGPCNP scope or competency (surgical conditions, complex subspecialty management), diagnostic uncertainty after appropriate primary care workup, treatment failure after appropriate first- and second-line management, red flag findings suggesting emergent or serious pathology, and conditions requiring procedures the AGPCNP cannot perform. The AGPCNP's value is not in managing everything independently but in knowing the boundary between primary care management and specialist-level management — and coordinating the interface between them so nothing falls through the gap.